| Literature DB >> 27529232 |
Aslı Neslihan Avan1, Sema Demirci Çekiç2, Seda Uzunboy3, Reşat Apak4,5.
Abstract
Development of easy, practical, and low-cost spectrophotometric methods is required for the selective determination of phenolic antioxidants in the presence of other similar substances. As electron transfer (ET)-based total antioxidant capacity (TAC) assays generally measure the reducing ability of antioxidant compounds, thiols and phenols cannot be differentiated since they are both responsive to the probe reagent. In this study, three of the most common TAC determination methods, namely cupric ion reducing antioxidant capacity (CUPRAC), 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt/trolox equivalent antioxidant capacity (ABTS/TEAC), and ferric reducing antioxidant power (FRAP), were tested for the assay of phenolics in the presence of selected thiol and protein compounds. Although the FRAP method is almost non-responsive to thiol compounds individually, surprising overoxidations with large positive deviations from additivity were observed when using this method for (phenols + thiols) mixtures. Among the tested TAC methods, CUPRAC gave the most additive results for all studied (phenol + thiol) and (phenol + protein) mixtures with minimal relative error. As ABTS/TEAC and FRAP methods gave small and large deviations, respectively, from additivity of absorbances arising from these components in mixtures, mercury(II) compounds were added to stabilize the thiol components in the form of Hg(II)-thiol complexes so as to enable selective spectrophotometric determination of phenolic components. This error compensation was most efficient for the FRAP method in testing (thiols + phenols) mixtures.Entities:
Keywords: ABTS; CUPRAC; FRAP; Hg(II)-thiol reaction; antioxidant capacity assays; thiol stabilization
Mesh:
Substances:
Year: 2016 PMID: 27529232 PMCID: PMC5000722 DOI: 10.3390/ijms17081325
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Thiol:Hg2+ mol ratio optimization for ferric reducing antioxidant power (FRAP) method.
| Sample | A(FRAP) 1 |
|---|---|
| Only GA | 0.3130 ± 0.016 |
| Only CYS | 0.0187 ± 0.019 |
| GA + CYS | 0.6455 ± 0.023 |
| GA + (1:0.5) CYS:Hg | 0.3865 ± 0.029 |
| GA + (1:1.0) CYS:Hg | 0.3149 ± 0.011 |
| GA + (1:2.5) CYS:Hg | 0.3226 ± 0.006 |
| GA + (1:5.0) CYS:Hg | 0.3656 ± 0.016 |
1 Absorbance = ± (t0.95s/N½); N = 5 ( = mean, s = standard deviation). GA, gallic acid; CYS, cysteine.
FRAP method results for individual thiols, phenolic antioxidant (AOx) solutions, and binary mixtures. In the experiments, 0.1 mL of 2.0 × 10−4 M thiols and different volumes of 1.0 × 10−4 M phenolic AOx compounds were used in the presence and absence of 5.0 × 10−4 M Hg2+.
| Volume (V) (mL) of Mixture Components (AOx and/or Thiol) | Aexp 1 (in the Absence of Hg2+) | Aexp 1 (in the Presence of Hg2+) | Relative Error % (in the Absence of Hg2+) | Relative Error % (in the Presence of Hg2+) |
|---|---|---|---|---|
| 0.10 mL HCYS | 0.0016 ± 0.002 | - | - | - |
| 0.10 mL NAC | 0.1430 ± 0.010 | |||
| 0.05 mL GA | 0.1557 ± 0.001 | - | - | - |
| 0.10 mL GA | 0.2867 ± 0.016 | |||
| 0.20 mL GA | 0.6060 ±0.008 | |||
| 0.30 mL GA | 0.9551 ± 0.005 | |||
| 0.05 mL GA + 0.1 mL HCYS | 0.3865 ± 0.024 | 0.1695 ± 0.003 | 148.2 | 8.9 |
| 0.10 mL GA + 0.1 mL HCYS | 0.5307 ± 0.034 | 0.3039 ± 0.013 | 85.1 | 6.0 |
| 0.20 mL GA + 0.1 mL HCYS | 1.0427 ± 0.025 | 0.6314 ± 0.009 | 72.1 | 4.2 |
| 0.30 mL GA + 0.1 mL HCYS | 1.3319 ± 0.012 | 0.9636 ± 0.007 | 39.4 | 0.9 |
| 0.05 mL GA + 0.1 mL NAC | 0.5217 ± 0.012 | 0.1580 ± 0.007 | 74.7 | 1.5 |
| 0.10 mL GA + 0.1 mL NAC | 0.7309 ± 0.032 | 0.3092 ± 0.021 | 70.1 | 7.8 |
| 0.20 mL GA + 0.1 mL NAC | 1.0345 ± 0.014 | 0.6636 ± 0.009 | 38.1 | 9.5 |
| 0.30 mL GA + 0.1 mL NAC | 1.3758 ± 0.039 | 0.9709 ± 0.021 | 25.3 | 1.6 |
1 Absorbance = ± (t0.95s/N½); N = 5 ( = mean, s = standard deviation). HCYS: homocysteine; NAC: N-acetyl-l-cysteine.
Figure 1Binary mixtures of 0.1 mL of 2.0 × 10−4 M cysteine (CYS) and 0.1–0.4 mL volumes of 1.0 × 10−4 M caffeic acid (CFA) (a) in the absence, and (b) presence, of 0.1 mL of 5.0 × 10−4 M Hg(Ac)2. FRAP: ferric reducing antioxidant power.
Optimization of thiol:Hg2+ mol ratio for the ABTS/TEAC method.
| Sample | A(ABTS/TEAC) |
|---|---|
| Ref. (without Hg) | 0.9306 |
| Ref. (1:1 Hg) | 0.9382 |
| Ref. (1:5 Hg) | 0.9277 |
| Ref. (1:10 Hg) | 0.9316 |
| Only CYS | 0.6967 |
| 1:1 CYS:Hg(II) | 0.8396 |
| 1:5 CYS:Hg(II) | 0.9146 |
| 1:10 CYS:Hg(II) | 0.9162 |
ABTS/TEAC: 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt/trolox equivalent antioxidant capacity; [30].
The absorbance drops (∆A) using the ABTS/TEAC method for individual components or binary mixtures consisting of 0.1 mL of 1.0 × 10−4 M HCYS (or NAC) and 0.05–0.25 mL of 5.0 × 10−5 M catechin (CAT).
| V (mL) of AOx (Thiol, Catechin, or Mixture) | ∆Aexp. 1 (without Hg2+) | ∆Aexp. 1 (with Hg2+) | RE% (without Hg2+) | RE% (with Hg2+) |
|---|---|---|---|---|
| 0.10 mL HCYS | 0.2011 ± 0.026 | - | - | - |
| 0.10 mL NAC | 0.2825 ± 0.034 | - | - | - |
| 0.05 mL CAT | 0.0738 ± 0.013 | 0.0482 ± 0.026 | - | - |
| 0.10 mL CAT | 0.1243 ±0.019 | 0.1134 ± 0.018 | - | - |
| 0.15 mL CAT | 0.2099 ± 0.024 | 0.1791 ± 0.008 | - | - |
| 0.20 mL CAT | 0.2658 ± 0.015 | 0.2912 ± 0.013 | - | - |
| 0.25 mL CAT | 0.3856 ± 0.008 | 0.3970 ± 0.028 | - | - |
| HCYS + 0.05 mL CAT | 0.2958 ± 0.015 | 0.0530 ± 0.019 | 7.6 | 5.4 |
| HCYS + 0.10 mL CAT | 0.3864 ± 0.015 | 0.1216 ± 0.027 | 18.8 | 5.2 |
| HCYS + 0.15 mL CAT | 0.4528 ± 0.013 | 0.1939 ± 0.021 | 10.2 | 7.0 |
| HCYS + 0.20 mL CAT | 0.5434 ± 0.018 | 0.3004 ± 0.037 | 16.4 | 2.4 |
| HCYS + 0.25 mL CAT | 0.6475 ± 0.023 | 0.4027 ± 0.021 | 10.4 | 1.1 |
| NAC + 0.05 mL CAT | 0.3110 ± 0.015 | 0.0754 ± 0.034 | 12.7 | 6.6 |
| NAC + 0.10 mL CAT | 0.3528 ± 0.010 | 0.1430 ± 0.010 | 13.3 | 8.5 |
| NAC + 0.15 mL CAT | 0.3889 ± 0.027 | 0.1898 ± 0.021 | 21.0 | 0.2 |
| NAC + 0.20 mL CAT | 0.4693 ± 0.009 | 0.2553 ± 0.022 | 14.4 | 10.0 |
| NAC + 0.25 mL CAT | 0.5227 ± 0.047 | 0.3363 ± 0.023 | 21.8 | 6.6 |
1 ∆A = ± (t0.95s/N½); N = 5 ( = mean, s = standard deviation).
Figure 2Binary mixtures of 0.1 mL of 1.0 × 10−4 M homocysteine (HCYS) and 0.1–0.4 mL volumes of 2.0 × 10−4 M CFA (a) in the absence, and (b) in the presence, of 0.1 mL of 1.0 × 10−3 M Hg(Ac)2. ABTS: 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt.
Cupric Ion Reducing Antioxidant Capacity (CUPRAC) absorbances of ternary mixtures of 0.2 mL volumes of 1.0 × 10−3 M thiol compounds (CYS, HCYS, NAC, GSH) with polyphenols, namely 2.0 × 10−4 M GA and 1.0 × 10−4 M CAT, EC, and CFA.
| Sample | Aexp. 1 | Atheo | RE% |
|---|---|---|---|
| CYS | 0.3061 ± 0.011 | - | - |
| GSH | 0.3222 ± 0.008 | - | - |
| CAT | 0.2274 ± 0.018 | - | - |
| EC | 0.2826 ± 0.016 | - | - |
| CFA | 0.1924 ± 0.024 | - | - |
| GA | 0.3988 ± 0.030 | - | - |
| CYS + EC + GA | 0.9930 ± 0.037 | 0.9875 | 0.6 |
| CYS + CFA + CAT | 0.7468 ± 0.028 | 0.7259 | 2.9 |
| CYS + GA + CAT | 0.9548 ± 0.038 | 0.9323 | 2.4 |
| CYS + CFA + EC | 0.7848 ± 0.028 | 0.7811 | 0.5 |
| GSH + EC + GA | 1.0131 ± 0.021 | 1.0036 | 1.0 |
| GSH + CFA + CAT | 0.7690 ± 0.021 | 0.7420 | 3.5 |
| GSH + GA + CAT | 0.9872 ± 0.027 | 0.9484 | 4.1 |
| GSH + CFA + EC | 0.8324 ± 0.019 | 0.7972 | 4.4 |
1 Absorbance= ± (t0.95s/N½); N = 5 ( = mean, s = standard deviation). GSH: glutathione; EC: epicatechin; CFA: caffeic acid.